[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"company:ESLA":3,"prompts:company:0001844417":26,"buybacks:0001844417:12":53,"months:0001844417:36":88,"side:events:0001844417":91,"filings:0001844417":103},{"status":4,"company":5,"choices":24,"suggestions":25},"found",{"cik":6,"name":7,"ticker":8,"exchange":9,"listings":10,"delisted":19,"coverage":20},"0001844417","Estrella Immunopharma, Inc.","ESLA","NASD",[11,15],{"ticker":8,"glr_ticker":12,"exchange":9,"type":13,"delisted_on":14},"NASD:ESLA","Common Stock",null,{"ticker":16,"glr_ticker":17,"exchange":9,"type":18,"delisted_on":14},"ESLAW","NASD:ESLAW","Equity WRT",false,{"buybacks":21},{"published":22,"published_at":23},true,"2026-11-17",[],[],{"placement":27,"items":28},"company",[29,34,38,42,48],{"id":30,"title":31,"hint":32,"kind":33,"question":31,"target":14},"asr-3nc2","How does a 3nc2 ASR look for me?","Pricer · discount, size vs. ADV","analyze",{"id":35,"title":36,"hint":37,"kind":33,"question":36,"target":14},"compare-3nc2-6nc4","Compare 3nc2 vs 6nc4","Two pricers side by side",{"id":39,"title":40,"hint":41,"kind":33,"question":40,"target":14},"backtest-2y","Backtest an ASR over 2 years","Backtest · chart",{"id":43,"title":44,"hint":45,"kind":46,"question":14,"target":47},"outstanding","What do I have outstanding?","Public · no email needed","page","buybacks#outstanding",{"id":49,"title":50,"hint":51,"kind":52,"question":14,"target":14},"convert-terms","Terms for a new convert","Coming next","soon",{"company":54,"data_as_of":55,"checked_at":56,"has_active_program":22,"authorized_total":57,"remaining_total":65,"nearest_expiration":68,"programs":70,"recent_quarters":86,"did_asr":19,"asrs":87},{"cik":6,"name":7,"ticker":8,"exchange":9},"2026-09-30","2026-11-17T19:39:57.856273Z",{"value":58,"status":59,"as_of":55,"source":60},1000000,"reported",{"accession":61,"form":62,"as_of":55,"filed_at":63,"url":64},"0001213900-26-120047","10-Q","2026-11-13","https:\u002F\u002Fwww.sec.gov\u002FArchives\u002Fedgar\u002Fdata\u002F1844417\u002F000121390026120047\u002F",{"value":58,"status":66,"as_of":55,"source":67},"estimated",{"accession":61,"form":62,"as_of":55,"filed_at":63,"url":64},{"value":14,"status":69,"as_of":14,"source":14},"not_found",[71],{"authorized":72,"unit":74,"authorized_as_stated":75,"price_as_of":14,"date_authorized":77,"expiration_date":80,"remaining":81,"remaining_as_stated":83,"description":85},{"value":58,"status":59,"as_of":55,"source":73},{"accession":61,"form":62,"as_of":55,"filed_at":63,"url":64},"usd",{"value":58,"status":59,"as_of":55,"source":76},{"accession":61,"form":62,"as_of":55,"filed_at":63,"url":64},{"value":78,"status":59,"as_of":55,"source":79},"2024-01-30",{"accession":61,"form":62,"as_of":55,"filed_at":63,"url":64},{"value":14,"status":69,"as_of":14,"source":14},{"value":58,"status":66,"as_of":55,"source":82},{"accession":61,"form":62,"as_of":55,"filed_at":63,"url":64},{"value":58,"status":66,"as_of":55,"source":84},{"accession":61,"form":62,"as_of":55,"filed_at":63,"url":64},"On January 30, 2024, the Company issued a press release announcing that its Board of Directors has authorized share repurchases of up to $ 1.0 million of its common stock.",[],[],{"company":89,"data_as_of":55,"items":90},{"cik":6,"name":7,"ticker":8,"exchange":9},[],{"view":92,"sort":93,"total":94,"generated_at":95,"items":96,"next_cursor":14},"all","newest",1,"2026-11-20T09:58:33.467888Z",[97],{"id":98,"type":99,"event_date":78,"company":100,"amount_usd":58,"amount_estimated":19,"shares":14,"headline":101,"source":102},"9549bc67-e292-5c56-93bc-8a88b9bff885","authorization_new",{"cik":6,"name":7,"ticker":8,"exchange":9},"Estrella Immunopharma, Inc. authorizes $1m share repurchase program",{"accession":61,"form":62,"as_of":55,"filed_at":63,"url":64},{"company":104,"items":105,"edgar_url":111},{"cik":6,"name":7,"ticker":8,"exchange":9},[106],{"accession":61,"form":62,"filed_at":107,"period_end":55,"url":64,"used_for":108},"2026-11-13T21:28:45Z",[109,110],"programs","remaining_total","https:\u002F\u002Fwww.sec.gov\u002Fcgi-bin\u002Fbrowse-edgar?action=getcompany&CIK=0001844417"]